07:00 , Oct 23, 2014 |  BC Innovations  |  Cover Story

Diagnosing resistance

It might be a day late and a dollar short, but the U.S. government is finally getting around to addressing what many experts think is the big unserved need in antibiotic resistance-new diagnostics. Faster, more...
08:00 , Feb 4, 2013 |  BC Week In Review  |  Clinical News

TruArray test for MRSA diagnostic data

An analysis of 87 bacterial isolates showed that Akonni's TruArray test for MRSA correctly classified 86 samples (98.8%) as being infected with MRSA or not. A retrospective analysis of 246 nasal swabs from a high-risk...
08:00 , Feb 4, 2013 |  BC Week In Review  |  Clinical News

TruArray test for MDR-TB diagnostic data

An analysis of 185 MDR-TB isolates showed that Akonni's TruArray test for MDR-TB correctly detected 193 of 196 (98.4%) drug-resistant mutations in the culture set. The test contains 96 probes for 39 drug-resistant mutations in...
08:00 , Feb 4, 2013 |  BC Week In Review  |  Clinical News

TruArray test for influenza diagnostic data

An analysis of 178 nasopharyngeal swabs in viral transport medium showed that Akonni's TruArray test for influenza definitively identified 164 samples (92%) as being infected with influenza, not infected with influenza or below the limit...
07:00 , May 3, 2012 |  BC Innovations  |  Strategy

Building bridges

Johnson & Johnson has joined the ranks of funders supporting the California Institute for Quantitative Biosciences Bridging-the-Gap Awards by providing two grants. The company is the first pharma to put money behind the awards. The Bridging-the-Gap...
07:00 , May 16, 2011 |  BC Week In Review  |  Company News

Akonni Biosystems, Seegene deal

Seegene granted Akonni a non-exclusive license to use its Dual Priming Oligo multiplex PCR technology in combination with Akonni's TruArray gel-drop microarray technology to develop point-of-care and high throughput screening assays to detect infectious pathogens...
08:00 , Feb 21, 2011 |  BC Week In Review  |  Company News

Akonni Biosystems, U.S. Army Medical Research Institute of Infectious Diseases deal

Akonni received from USAMRIID a license to access the institute's nucleic acid sequences, primers and probes for biological threat agents. Akonni will combine the information with its TruArray microarray technologies, TruTip sample extraction kits and...
08:00 , Feb 7, 2011 |  BC Week In Review  |  Company News

Akonni Biosystems sales and marketing update

Akonni launched its TruSentry system to early access customers for research uses only. TruSentry identifies infectious microorganisms and drug resistant variants. TruSentry uses Freedom EVO 200 liquid handling system from Tecan AG (SIX:TECN,...